Researchers are pioneering a promising new frontier in cancer treatment with dendritic cell (DC) immunotherapy for glioblastoma, one of the most aggressive and treatment-resistant brain cancers. Despite decades of research, glioblastoma remains a critical unmet medical need, with limited therapeutic options and poor survival rates. DC immunotherapy offers a novel approach by harnessing the patient’s […]

The field of nuclear medicine is undergoing a transformative shift, driven by advances in radiopharmaceuticals—a powerful class of targeted drugs that combine radioactive isotopes with biological molecules to diagnose and treat cancer with unprecedented precision. With innovations in PET imaging and therapeutic radioligands, these tools are reshaping oncology by enabling earlier detection, personalized treatment, and […]